Phone
Address Talkabouturology, Nizhny Novgorod, Russia
Skype ukitcom
Email Talkabouturology@list.ru
                                    Talk about urology

Back to the list

The FDA has granted accelerated approval to Trodelvy® (sacituzumab govitecan-hziy) for the treatment of locally advanced or metastatic urothelial cancer in patients previously treated with a platinum-containing chemotherapy and either a PD-1 or a PD-L1 inhibitor.

https://www.renalandurologynews.com/home/news/urology/bladder-cancer/trodelvy-sacituzumab-govitecan-hziy-approved-urothelial-cancer-treatment/?utm_source=social&utm_medium=facebook&utm_content=671dbea7-2d0a-456b-a7ad-6636e51e2f80&utm_campaign=run_daily_posts